Training future leaders in Alzheimer's disease research using data science and engineering.

Who could benefit from this research

What this research studies

This program at Rensselaer Polytechnic Institute focuses on training predoctoral students to become leaders in Alzheimer's disease research. It combines data science, engineering, and biology to tackle challenges in Alzheimer's disease and related dementias. Students will engage in interdisciplinary projects and coursework, gaining hands-on experience in areas such as medical imaging and drug development. The program also collaborates with the Alzheimer's Disease Research Center at Mount Sinai, providing access to clinical training and research opportunities.

Why it matters

Where this research is happening

• Rensselaer Polytechnic Institute
  Troy, United States Active

Researchers

• Principal investigator: Wang, Chunyu — Rensselaer Polytechnic Institute
• Study coordinator: Wang, Chunyu

Related research

Other NIH-funded projects on the same topics.

• Understanding how brain activity changes may drive Alzheimer’s disease progression in a mouse model

  Researchers are testing how changes in brain signals and protein cleanup processes affect the development of Alzheimer’s disease in mice.

  NIH research Nathan S. Kline Institute for Psych Res · Orangeburg, United States · NIH-11627965

• Thiamine-boosting therapy for Alzheimer’s: understanding how benfotiamine may reduce harmful AGE in DP patients

  A medication-based approach using high-dose vitamin B1 (benfotiamine) is studied to help people with Alzheimer's by reducing harmful sugar-related molecules.

  NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11627145

• Non-invasive tears biomarker for early Alzheimer's in LMICs

  A low-cost, tear-based biomarker approach aims to detect early Alzheimer’s disease in older adults in Peru and similar settings.

  NIH research Univ of North Carolina Chapel Hill · Chapel Hill, United States · NIH-11623923

• Turning APOE4 into protective APOE2 or APOE3Christchurch to help with Alzheimer’s

  A patient-facing explanation of a treatment idea that aims to change a genetic risk factor for Alzheimer's disease in the brain.

  NIH research Weill Medical Coll of Cornell Univ · New York, United States · NIH-11622616

• Telomerase in Alzheimer’s Disease: how aging biology could influence memory and brain health

  Researchers are exploring a new brain-aging mechanism linked to telomerase, with potential to slow or modify Alzheimer’s disease in people and improve cognitive function.

  NIH research University of Tx Md Anderson Can Ctr · Houston, United States · NIH-11622615

• Biomarkers of Alzheimer’s Disease: Sensory, Motor, and Cognitive Clues

  Researchers are testing simple sensory and movement tasks to find early signs of Alzheimer’s disease so they can diagnose and treat people sooner.

  NIH research University of Delaware · Newark, UNITED STATES · NIH-11619072

About this research

1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.